The benefits of Oral Contraceptives

article OA: closed CC0
View on OpenAlex View at publisher

Abstract

Although the adverse effects of oral contraceptives (OCs) should be given serious consideration, the many beneficial effects of OC use should also receive recognition. The main advantage of the pill is its effectiveness as a method of reversible fertility control, enabling women to be free of the fear of unwanted pregnancy and its psychological, social, and physical implications. In addition, however, there are numerous noncontraceptive advantages. Many symptoms related to ovulation and menstruation, such as dysmenorrhea, premenstrual syndrome, irregular menses, menorrhagia, and ovulation pain, disappear or are greatly reduced through OC use, especially in young women. Endometriosis and functional ovarian cysts are less common in OC users, and the risk of pelvic inflammatory disease in OC users is about half that in nonusers of contraception. The reduced menstrual blood loss resulting from OC use cuts the risk of iron deficiency anemia by 50%. In addition, the pill has a protective effect against benign breast disease and appears to reduce the risk of ovarian and endometrial cancer. Other beneficial effects include a reduction in the rate of thyroid disease, rheumatoid arthritis, and possibly duodenal ulcers.

My notes (saved in your browser only)

Condition tags

endometriosisdysmenorrhea

MeSH descriptors

Contraceptives, Oral Genital Diseases, Female Contraceptives, Oral Female Genital Diseases, Female Humans

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

References (12)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:09:45.632124+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK